VRTX fundamentals
Vertex Pharmaceuticals Incorporated earnings per share and revenue
VRTX earnings per share for the last quarter are 3.98 USD whereas the estimation was 4.02 USD which accounts for -0.90% surprise. Company revenue for the same period amounts to 2.91 B USD despite the estimated figure of 2.78 B USD. Estimated earnings per share for the next quarter are 4.27 USD, and revenue is expected to reach 2.86 B USD. Also watch annual changes over time to get a bigger picture of VRTX earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate4.27USD
Revenue estimate2.86 BUSD
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−15.00
−10.00
−5.00
0.00
5.00
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
3.05
3.89
4.08
4.20
4.76
−12.83
4.38
3.98
—
—
—
—
Estimate
3.01
3.86
3.93
4.07
4.07
−11.63
4.08
4.02
4.27
4.31
4.55
4.81
Surprise
+1.23%
+0.80%
+3.72%
+3.27%
+16.87%
−10.36%
+7.41%
−0.90%
—
—
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
800.00 M
1.60 B
2.40 B
3.20 B
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
2.37 B
2.49 B
2.48 B
2.52 B
2.69 B
2.65 B
2.77 B
2.91 B
—
—
—
—
Estimate
2.34 B
2.42 B
2.50 B
2.51 B
2.58 B
2.66 B
2.69 B
2.78 B
2.86 B
2.91 B
3.03 B
3.17 B
Surprise
+1.66%
+3.00%
−0.72%
+0.19%
+4.24%
−0.68%
+3.22%
+4.59%
—
—
—
—